Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) Short Interest Up 112.6% in January

Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) was the target of a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 32,118 shares, a growth of 112.6% from the January 15th total of 15,105 shares. Based on an average daily trading volume, of 31,647 shares, the short-interest ratio is presently 1.0 days. Currently, 0.3% of the shares of the company are sold short. Currently, 0.3% of the shares of the company are sold short. Based on an average daily trading volume, of 31,647 shares, the short-interest ratio is presently 1.0 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. PNC Financial Services Group Inc. acquired a new stake in Radiopharm Theranostics in the second quarter valued at $37,000. Marex Group plc purchased a new position in shares of Radiopharm Theranostics in the 4th quarter valued at about $54,000. Finally, Jane Street Group LLC acquired a new stake in shares of Radiopharm Theranostics in the fourth quarter valued at about $76,000.

Analyst Ratings Changes

Several analysts have commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Radiopharm Theranostics in a research note on Thursday, January 22nd. B. Riley Financial restated a “buy” rating and set a $16.00 price target (up previously from $13.00) on shares of Radiopharm Theranostics in a research note on Tuesday, December 16th. Finally, Wall Street Zen lowered shares of Radiopharm Theranostics to a “strong sell” rating in a research report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Radiopharm Theranostics currently has an average rating of “Buy” and an average price target of $15.33.

Radiopharm Theranostics Stock Down 1.4%

Shares of RADX opened at $5.00 on Friday. The stock’s 50 day moving average is $5.15 and its two-hundred day moving average is $5.38. Radiopharm Theranostics has a twelve month low of $3.50 and a twelve month high of $16.25.

Radiopharm Theranostics Company Profile

Radiopharm Theranostics, Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of radiopharmaceutical products for both diagnostic imaging and targeted radiotherapeutic applications. By harnessing the unique properties of radioisotopes, the company aims to improve the precision of disease detection and deliver therapeutic payloads directly to diseased tissues, particularly in oncology.

The company’s research and development efforts are concentrated on a pipeline of radioligand therapies and companion diagnostic agents designed to address a variety of tumor types.